Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-104811
Filing Date
2025-11-03
Accepted
2025-10-31 19:39:12
Documents
86
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0261774-10q_abvc.htm   iXBRL 10-Q 1557996
2 CERTIFICATION ea026177401ex31-1_abvc.htm EX-31.1 8288
3 CERTIFICATION ea026177401ex31-2_abvc.htm EX-31.2 8303
4 CERTIFICATION ea026177401ex32-1_abvc.htm EX-32.1 4246
5 CERTIFICATION ea026177401ex32-2_abvc.htm EX-32.2 4216
  Complete submission text file 0001213900-25-104811.txt   10399859

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20250930.xsd EX-101.SCH 82739
7 XBRL CALCULATION FILE abvc-20250930_cal.xml EX-101.CAL 52593
8 XBRL DEFINITION FILE abvc-20250930_def.xml EX-101.DEF 467946
9 XBRL LABEL FILE abvc-20250930_lab.xml EX-101.LAB 789737
10 XBRL PRESENTATION FILE abvc-20250930_pre.xml EX-101.PRE 499203
88 EXTRACTED XBRL INSTANCE DOCUMENT ea0261774-10q_abvc_htm.xml XML 1311462
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 251441775
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)